Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
SMALL CAP BASIC
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 1.18 ▲ 0.03 (2.61%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Novabay Pharmaceuticals | NBY | AMEX | Ordinary Share |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.0685 | 6.33% | 1.15 | 1.22 | 1.05 | 1.05 | 1.08 | 18:00:51 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 985 | 547,350 | $ 1.16 | $ 632,437 | 4,570,214 | 0.229 - 4.78 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 20:00:00 | 200 | $ 1.15 | USD |
Novabay Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 23.62M | 20.54M | $ -6.55M | -0.46 | -3.61 | 18.76M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 1.51M | $ - | 0.00% | - | - |
Novabay Pharmaceuticals News
Current Report Filing (8-k) Edgar (US Regulatory) • Mon Jul 15, 2019 8:31 AM (5 days ago)
NovaBay Pharmaceuticals Issues Letter to Stockholders Business Wire • Mon Jul 15, 2019 6:50 AM (5 days ago)
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) • Wed Jul 03, 2019 2:27 PM (2 weeks ago)
Current Report Filing (8-k) Edgar (US Regulatory) • Mon Jul 01, 2019 8:33 AM (3 weeks ago)
NovaBay Pharmaceuticals Plan of Compliance Accepted by NYSE Business Wire • Mon Jul 01, 2019 6:50 AM (3 weeks ago)
Current Report Filing (8-k) Edgar (US Regulatory) • Wed Jun 26, 2019 4:32 PM (3 weeks ago)
NovaBay Pharmaceuticals Raises $2.4 Million in a Private Placement Business Wire • Wed Jun 26, 2019 4:05 PM (3 weeks ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NBY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.39 | 1.4707 | 1.05 | 1.2638 | 298k | -0.24 | -17.27% |
| 1 Month | 2 | 2.1 | 1.05 | 1.6544 | 503k | -0.85 | -42.50% |
| 3 Months | 0.98 | 4.78 | 0.229 | 2.3185 | 3M | 0.17 | 17.35% |
| 6 Months | 1.11 | 4.78 | 0.229 | 2.3078 | 1M | 0.04 | 3.60% |
| 1 Year | 2.45 | 4.78 | 0.229 | 2.2984 | 678k | -1.3 | -53.06% |
| 3 Years | 2.44 | 5.29 | 0.229 | 2.4235 | 246k | -1.29 | -52.87% |
| 5 Years | 24.5 | 32.5 | 0.229 | 6.9088 | 238k | -23.35 | -95.31% |
Novabay Pharmaceuticals Description
| NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing and developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX and CELLERX. |
